CNS Pharmaceuticals CNSP
NASDAQ CNSP
$4.82 -0.16 (-3.31%)
As of: Oct 21, 2026 · 12:16 PM EDT

CNS Pharmaceuticals (CNSP) Receivables (2022 - 2023)

Updated

CNS Pharmaceuticals' Receivables was $197,605 in Q4 2023, down 49.9% from $394,484 a year earlier and unchanged from the prior quarter.

Analysis

CNS Pharmaceuticals (CNSP) Receivables (2022 - 2023) Analysis & Trends

From Q4 2022 onward, CNS Pharmaceuticals has reported Receivables for 4 quarters.

  • In earlier years, Receivables was $394,484 in FY2022.
  • Quarterly Receivables has moved between $197,605 (Q2 2023) and $394,484 (Q4 2022) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 23.48 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 19.05 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 13.82 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 12.56 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 9.64 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 15.68 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 10.23 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 5.06 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 12.49 Bn
10 CNS Pharmaceuticals 2.14 Mn -40.10 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 197,605.00
Sep 30, 2023 197,605.00
Jun 30, 2023 197,605.00
Dec 31, 2022 394,484.00
API Access

CNS Pharmaceuticals Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables&ticker=CNSP&period=max&api_key=YOUR_API_KEY